Table 3.
Replicates (n = 24) from a serial dilution containing approximately 25-50 copies of SARS-CoV-2 (patient sample NP swab in UTM viral copies confirmed by digital droplet PCR) per reaction at approximately 1-2X LOD was tested using dual target RT-LAMP.
NP swab sample (25−50 copies per reaction) | S and RdRP RT-LAMP | Minutes for positive call | MS2 LAMP | Minutes for positive call | E-gene PCR | Ct value-E gene |
---|---|---|---|---|---|---|
Replicate 1 | Pos | 11.78 | Pos | 11.05 | Pos | 31.79 |
Replicate 2 | Pos | 12.47 | Pos | 10.87 | Pos | 31.13 |
Replicate 3 | Pos | 18.2 | Pos | 10.69 | Pos | 31.33 |
Replicate 4 | Neg | N/A | Pos | 10.9 | Pos | 31.58 |
Replicate 5 | Pos | 11.28 | Pos | 10.76 | Pos | 31.17 |
Replicate 6 | Pos | 10.18 | Pos | 11.05 | Pos | 31.86 |
Replicate 7 | Pos | 11.28 | Pos | 11.05 | Pos | 31.71 |
Replicate 8 | Pos | 11.71 | Pos | 10.95 | Pos | 30.61 |
Replicate 9 | Pos | 9.32 | Pos | 11.04 | Pos | 30.76 |
Replicate 10 | Pos | 11.04 | Pos | 10.57 | Pos | 31.02 |
Replicate 11 | Pos | 10.88 | Pos | 10.86 | Pos | 30.82 |
Replicate 12 | Pos | 10.52 | Pos | 10.96 | Pos | 30.86 |
Replicate 13 | Pos | 21.98 | Pos | 11.33 | Pos | 30.94 |
Replicate 14 | Pos | 11.15 | Pos | 11.01 | Pos | 30.86 |
Replicate 15 | Pos | 21.09 | Pos | 10.9 | Pos | 32.3 |
Replicate 16 | Pos | 12.67 | Pos | 10.34 | Pos | 31.12 |
Replicate 17 | Pos | 10.98 | Pos | 11.2 | Pos | 31.08 |
Replicate 18 | Pos | 16.13 | Pos | 10.79 | Pos | 31.65 |
Replicate 19 | Pos | 9.94 | Pos | 10.7 | Pos | 30.39 |
Replicate 20 | Pos | 11.02 | Pos | 10.62 | Pos | 31.84 |
Replicate 21 | Pos | 25.28 | Pos | 10.64 | Pos | 31.53 |
Replicate 22 | Pos | 10.32 | Pos | 10.97 | Pos | 31.04 |
Replicate 23 | Pos | 10.94 | Pos | 10.34 | Pos | 31.62 |
Replicate 24 | Pos | 10.71 | Pos | 10.57 | Pos | 31.62 |
Positive Control | Pos | 6.78 | Pos | 9.02 | Pos | 20.23 |
Negative Control 1 | Neg | NA | Neg | NA | Neg | NA |
Negative Control 2 | Neg | NA | Neg | NA | Neg | NA |
Negative Control 3 | Neg | NA | Neg | NA | Neg | NA |